Literature DB >> 16528087

Monitoring HIV treatment in developing countries.

Serena P Koenig1, Daniel R Kuritzkes, Martin S Hirsch, Fernet Léandre, Joia S Mukherjee, Paul E Farmer, Carlos del Rio.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16528087      PMCID： PMC1397781          DOI： 10.1136/bmj.332.7541.602

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Community-based approaches to HIV treatment in resource-poor settings.

Authors:  P Farmer; F Léandre; J S Mukherjee; M Claude; P Nevil; M C Smith-Fawzi; S P Koenig; A Castro; M C Becerra; J Sachs; A Attaran; J Y Kim
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

2.  Antiretroviral treatment in resource-poor settings: clinical research priorities.

Authors:  Miriam Rabkin; Wafaa El-Sadr; David A Katzenstein; Joia Mukherjee; Henry Masur; Peter Mugyenyi; Paula Munderi; Janet Darbyshire
Journal:  Lancet       Date:  2002-11-09       Impact factor: 79.321

3.  Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.

Authors:  Rajesh Gupta; Alexander Irwin; Mario C Raviglione; Jim Yong Kim
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

4.  Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Authors:  P Richard Harrigan; Robert S Hogg; Winnie W Y Dong; Benita Yip; Brian Wynhoven; Justin Woodward; Chanson J Brumme; Zabrina L Brumme; Theresa Mo; Chris S Alexander; Julio S G Montaner
Journal:  J Infect Dis       Date:  2004-12-22       Impact factor: 5.226

5.  Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe.

Authors: 
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

6.  Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.

Authors:  Rafael de la Rosa; Ezequiel Ruíz-Mateos; Amalia Rubio; María Antonia Abad; Alejandro Vallejo; Laura Rivero; Miguel Genebat; Armando Sánchez-Quijano; Eduardo Lissen; Manuel Leal
Journal:  J Antimicrob Chemother       Date:  2003-12-04       Impact factor: 5.790

7.  The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.

Authors:  Hillard S Weinstock; Irum Zaidi; Walid Heneine; Diane Bennett; J Gerardo Garcia-Lerma; John M Douglas; Marlene LaLota; Gordon Dickinson; Sandra Schwarcz; Lucia Torian; Deborah Wendell; Sindy Paul; Garald A Goza; Juan Ruiz; Brian Boyett; Jonathan E Kaplan
Journal:  J Infect Dis       Date:  2004-05-21       Impact factor: 5.226

8.  Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.

Authors:  David Coetzee; Katherine Hildebrand; Andrew Boulle; Gary Maartens; Francoise Louis; Veliswa Labatala; Hermann Reuter; Nonthutuzelo Ntwana; Eric Goemaere
Journal:  AIDS       Date:  2004-04-09       Impact factor: 4.177

9.  From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.

Authors:  H L Behforouz; P E Farmer; J S Mukherjee
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

10.  Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

Authors:  Ajay K Sethi; David D Celentano; Stephen J Gange; Richard D Moore; Joel E Gallant
Journal:  Clin Infect Dis       Date:  2003-09-19       Impact factor: 9.079
View more
  15 in total

1.  Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico.

Authors:  Myres W Tilghman; Don Diego Guerena; Alexei Licea; Josué Pérez-Santiago; Douglas D Richman; Susanne May; Davey M Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

2.  Burkitt's lymphoma mimicking EBV disease as first sign of vertical HIV infection in an adolescent.

Authors:  Veronica Santilli; Nadia Mora; Angela Aquilani; Hyppolite K Tchidjou; Giuseppe Pontrelli; Rita De Vito; Alessandra Lombardi; Stefania Bernardi; Paolo Palma
Journal:  Ital J Pediatr       Date:  2010-04-23       Impact factor: 2.638

3.  Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.

Authors:  C William Wester; Hermann Bussmann; John Koethe; Claire Moffat; Sten Vermund; Max Essex; Richard G Marlink
Journal:  HIV Ther       Date:  2009-09-01

4.  A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.

Authors:  John R Koethe; Andrew O Westfall; Dora K Luhanga; Gina M Clark; Jason D Goldman; Priscilla L Mulenga; Ronald A Cantrell; Benjamin H Chi; Isaac Zulu; Michael S Saag; Jeffrey S A Stringer
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

5.  Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa.

Authors:  R E Barth; J T M van der Meer; A I M Hoepelman; P A Schrooders; D A van de Vijver; S P M Geelen; H A Tempelman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-16       Impact factor: 3.267

6.  The use of pooled viral load testing to identify antiretroviral treatment failure.

Authors:  Davey M Smith; Susanne J May; Josué Pérez-Santiago; Matthew C Strain; Caroline C Ignacio; Richard H Haubrich; Douglas D Richman; Constance A Benson; Susan J Little
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

7.  Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.

Authors:  Maya L Petersen; Mark J van der Laan; Sonia Napravnik; Joseph J Eron; Richard D Moore; Steven G Deeks
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

8.  Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings.

Authors:  Alexandra Calmy; Eric Balestre; Fabrice Bonnet; Andrew Boulle; Eduardo Sprinz; Robin Wood; Eric Delaporte; Eugène Messou; James McIntyre; Kamal Marhoum El Filali; Mauro Schechter; N Kumarasamy; David Bangsberg; Patrick McPhail; Stefaan Van Der Borght; Carlos Zala; Matthias Egger; Rodolphe Thiébaut; François Dabis
Journal:  BMC Infect Dis       Date:  2012-06-28       Impact factor: 3.090

9.  Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.

Authors:  Jonathan Mermin; John P Ekwaru; Willy Were; Richard Degerman; Rebecca Bunnell; Frank Kaharuza; Robert Downing; Alex Coutinho; Peter Solberg; Lorraine N Alexander; Jordan Tappero; James Campbell; David M Moore
Journal:  BMJ       Date:  2011-11-09

10.  Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.

Authors:  Gonzague Jourdain; Sophie Le Cœur; Nicole Ngo-Giang-Huong; Patrinee Traisathit; Tim R Cressey; Federica Fregonese; Baptiste Leurent; Intira J Collins; Malee Techapornroong; Sukit Banchongkit; Sudanee Buranabanjasatean; Guttiga Halue; Ampaipith Nilmanat; Nuananong Luekamlung; Virat Klinbuayaem; Apichat Chutanunta; Pacharee Kantipong; Chureeratana Bowonwatanuwong; Rittha Lertkoonalak; Prattana Leenasirimakul; Somboon Tansuphasawasdikul; Pensiriwan Sang-A-Gad; Panita Pathipvanich; Srisuda Thongbuaban; Pakorn Wittayapraparat; Naree Eiamsirikit; Yuwadee Buranawanitchakorn; Naruepon Yutthakasemsunt; Narong Winiyakul; Luc Decker; Sylvaine Barbier; Suporn Koetsawang; Wasna Sirirungsi; Kenneth McIntosh; Sombat Thanprasertsuk; Marc Lallemant
Journal:  PLoS Med       Date:  2013-08-06       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.